InvestorsHub Logo
Followers 240
Posts 28294
Boards Moderated 0
Alias Born 07/08/2009

Re: powerbattles post# 4644

Thursday, 03/14/2024 6:08:47 AM

Thursday, March 14, 2024 6:08:47 AM

Post# of 6607
Seems like Jaguar is preparing for Mytesi to be used on a wider scale by making it easier to use the drug for patients and physicians....I take that as a good sign that phase III will have FDA approval.

"We remain committed to reducing access and reimbursement barriers for Mytesi patients."

Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company is developing an artificial intelligence-powered web portal for U.S. healthcare professionals to support patient access to Mytesi (crofelemer), the Company's FDA-approved antidiarrheal prescription drug indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.

You got to be tough to be green in a pink world!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News